查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1730667

末稍血管設備的全球市場:各產品類型，各用途，各終端用戶，各地區，機會，預測，2018年～2032年

Peripheral Vascular Devices Market Assessment, By Product Type, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 248 Pages | 商品交期: 3-5個工作天內

價格

全球週邊血管器械市場規模預計將從2024年的104.9億美元成長至2032年的170.1億美元，在2025-2032年的預測期內，複合年增長率為6.23%。市場成長的動力源於人們對血管健康的日益重視、臨床試驗數量的增加以及世界各地各種心臟疾病（包括週邊動脈疾病 (PAD)）盛行率的上升。美國心臟協會估計，週邊動脈疾病 (PAD) 影響全球約 2 億人，但某些人群的臨床影響和盛行率更高。

由於肥胖、糖尿病和高血壓等生活方式相關疾病的增多，對新型、先進、高效的血管介入治療的需求持續增長，而這些疾病是血管疾病的主要危險因素。日益增多的宣傳活動、政府舉措以及影像技術的進步，正在幫助醫療保健專業人員及早診斷疾病並儘早開始治療，從而支持市場擴張。

心血管疾病發生率的上升也在推動市場需求。由於久坐不動的生活方式、人口老化加劇、不良的飲食習慣等原因，動脈硬化、週邊動脈疾病 (PAD) 和靜脈曲張等疾病變得越來越普遍。這些疾病的高盛行率促使醫療保健專業人員採用現代、高效、微創的解決方案進行早期診斷和治療。週邊血管器械的進步使醫療保健專業人員能夠治療阻塞、促進血液流動，並降低中風和截肢的風險。

本報告提供全球末稍血管設備市場相關調查，提供市場概要，以及各產品類型，各用途，各終端用戶，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 美國的關稅的影響

第4章 摘要整理

第5章 全球末稍血管設備市場預測，2018年～2032年

  • 市場規模分析與預測
  • 市場佔有率分析與預測
    • 各產品類型
      • 末梢血管支架
      • 血管成形術用氣球
      • 斑塊修正設備
      • 下腔靜脈(IVC)過濾器
      • 血液循環動態血流調節設備
      • 導管
      • 其他
    • 各用途
      • 週邊動脈疾病(PAD)
      • 動脈瘤
      • 靜脈血栓栓塞症
      • 其他
    • 各終端用戶
      • 醫院和外科中心
      • 門診病人手術中心(ASC)
      • 學術研究機關
      • 其他
    • 各地區
      • 北美
      • 歐洲
      • 亞太地區
      • 南美
      • 中東·非洲
    • 各企業市場佔有率分析(前五名公司以及其他- 各金額，2024年)
  • 2024年的市場地圖分析

第6章 北美的末稍血管設備市場預測，2018年～2032年

  • 市場規模分析與預測
  • 市場佔有率分析與預測
  • 各國市場評估
    • 美國
    • 加拿大
    • 墨西哥

第7章 歐洲的末稍血管設備市場預測，2018年～2032年

  • 德國
  • 法國
  • 義大利
  • 英國
  • 俄羅斯
  • 荷蘭
  • 西班牙
  • 土耳其
  • 波蘭

第8章 亞太地區的末稍血管設備市場預測，2018年～2032年

  • 印度
  • 中國
  • 日本
  • 澳洲
  • 越南
  • 韓國
  • 印尼
  • 菲律賓

第9章 南美的末稍血管設備市場預測，2018年～2032年

  • 巴西
  • 阿根廷

第10章 中東·非洲的末稍血管設備市場預測，2018年～2032年

  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第11章 需求供給分析

第12章 進出口的分析

第13章 價值鏈分析

第14章 波特的五力分析

第15章 大環境分析

第16章 價格分析

第17章 市場動態

  • 市場促進因素
  • 市場課題

第18章 市場趨勢與發展

第19章 法規情形

第20章 產品的銷售和革新

第21章 案例研究

第22章 競爭情形

  • 前五名市場領導的競爭矩陣
  • 前五名參與企業的SWOT分析
  • 前10名市場主要企業的形勢
    • Boston Scientific Corporation
    • Koninklijke Philips N.V
    • Abbott Laboratories
    • Edward Lifesciences Corporation
    • Medtronic Inc.
    • Teleflex Incorporated
    • Becton, Dickinson, and Company
    • Edward Lifesciences Corporation
    • Terumo Corporation
    • Stryker Corporation

第23章 策略性建議

第24章 關於調查公司·免責聲明

Product Code: MX13152

Global peripheral vascular devices market is projected to witness a CAGR of 6.23% during the forecast period 2025-2032, growing from USD 10.49 billion in 2024 to USD 17.01 billion in 2032. The market's growth can be attributed to the rising emphasis on vascular health, the increasing number of clinical trials, and growing prevalence of various cardiac conditions, including peripheral arterial disease (PAD) in different regions across the globe. The American Heart Association estimates that PAD affects approximately 200 million individuals across the globe, though certain demographic groups experience higher clinical effects and prevalence of PAD.

There is an ever-increasing demand for novel, advanced, and efficient vascular interventions due to the rise in lifestyle disorders including obesity, diabetes mellitus, and hypertension, major risk factors for vascular diseases. The rising number of awareness campaigns, government initiatives, and advancements in diagnostic imaging technology are allowing healthcare professionals to provide early diagnosis of the condition and start the treatment sooner, supporting the market's expansion.

The rise in the number of cardiovascular and vascular disorders is also bolstering the market's demand. Conditions such as atherosclerosis, PAD, and varicose veins are becoming increasingly common, due to sedentary lifestyles, expansion of the aging population, and poor dietary habits. The high prevalence of such conditions is encouraging medical professionals to introduce modern, efficient, and minimally invasive solutions for early diagnosis and treatment. Advancements in peripheral vascular devices are allowing healthcare professionals to treat blockages, facilitate blood flow, and reduce the chances of stroke and amputation.

Technological Innovations Drive Market Growth

Technological advancements are allowing the leading market players to improve the safety, performance, and effectiveness of peripheral vascular interventions, thus improving patient outcomes. Easy availability of the newer generation of the drug-eluting stent and balloon, bioresorbable scaffolds, and newer guidewire technologies have led to improved procedural precision. Additionally, imaging-guided interventions have changed vascular surgery by assisting accurate navigation in real-time, fewer complications in procedures, and higher accuracy. The companies are also heavily investing in research and development to bring to devices that are easy to use, flexible, and durable, enhancing physician convenience. Artificial intelligence and machine learning algorithms have now begun to enter vascular diagnostics to prioritize personalized treatment plans and earlier detection of disease. These technological advancements are giving better clinical outcomes and making vascular procedures more cost-effective, thus encouraging companies to expand their product portfolios. For instance, in September 2024, Shockwave Medical, Inc. launched the Shockwave E8 Peripheral IVL Catheter, following clearance by the U.S. FDA. The catheter is designed for optimizing the treatments for patients with below the knee PAD and calcified femoropopliteal.

Rising Research Activities Support Market Expansion

Research activities drive market growth by improving clinical outcomes, fostering innovation, and bolstering the selection of treatment options available. Rising investments in research studies and clinical trials by leading market players and medical device companies are propelling the availability of advanced technologies and medical solutions such as novel stent systems, drug-coated balloons, and atherectomy devices. Such innovations address the complex vascular disorders in a more effective manner, enhancing the quality of life and safety of the patient population, bolstering the demand for novel, innovative solutions.

Additionally, the key players of the market are also investing in research studies and clinical trials to demonstrate the effectiveness and safety of various peripheral vascular devices to boost physician confidence and propel their utilization. For instance, in November 2024, Abbott Laboratories released data from the second year of the LIFE-BTK clinical trial that demonstrated the effectiveness of Esprit BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK) in patients with severe PAD below the knee.

Angioplasty Balloons Account for Significant Share of the Market

The segment's dominance can be attributed to the rising prevalence of cardiovascular diseases, especially coronary artery disease. These medical devices are used during minimally invasive procedures to open blocked or narrow arteries, reducing symptoms such as PAD and angina, by restoring effective blood flow. The rising efforts of the leading market players to introduce technologically advanced devices including drug-coated balloons to reduce the risk of restenosis and improve patient outcomes is further supporting the segment's expansion.

As the aging population expands and the incidences of obesity continue to rise, the preference for minimally invasive procedures is increasing, thus encouraging the leading medical device companies to introduce new products and technologies. For instance, in August 2024, Teleflex Incorporated received 510(k) clearance from the Food and Drug Administration (FDA) for its percutaneous transluminal coronary angioplasty perfusion balloon catheter for balloon dilation of coronary artery and coronary bypass graft stenoses.

North America Holds Major Market Share

The market's growth in North America can be attributed to the expansion of the geriatric population, advancements in medical technology, easy availability and adoption of novel medical solutions, and rising incidences of PAD in countries such as the United States and Canada. As per the estimates of the American Heart Association, 7-12 million individuals in the United States suffer from PAD. The increasing prevalence of PAD can be attributed to the rising cases of diabetes, high blood pressure, and smoking.

Meanwhile, the market in the Asia-Pacific is expected to witness rapid growth over the forecast period owing to rising incidences of PAD and increasing prevalence of diabetes. As per the estimates of the World Health Organization (WHO), approximately 77 million people above the age of 18 suffer from diabetes in India. Additionally, the rising preference for advanced treatment solutions and minimally invasive technologies coupled with growing emphasis on improving healthcare infrastructure are further expected to propel the market's expansion in the region.

Impact of the U.S. Tariff on Global Peripheral Vascular Devices Market

The key players of the market, such as Medtronic Inc. and Abbott Laboratories, are expected to face various challenges with the introduction of the tariffs. The increased costs may result in higher prices for consumers and potential reductions in research and development budgets, impacting innovation and availability of new devices.

Additionally, a large number of these devices rely on imported materials such as aluminum, steel, and specialized polymers, high tariffs on such materials are expected to disrupt supply chains and result in delays, boosting operational costs for medical device manufacturers. Healthcare providers and small hospitals are expected to experience financial strain due to the increased costs of medical devices, potentially leading to reduced accessibility to essential medical equipment for the patient population.

Key Players Landscape and Outlook

The key players of the market are focusing on launching new products and technologies in order to enhance physician convenience and expand their presence in the market. For instance, in June 2024, Koninklijke Philips N.V launched the Duo venous stent system for treating symptomatic venous outflow obstruction in patients suffering from chronic venous insufficiency. The innovative device was developed by Vesper Medical, Inc., a wholly owned subsidiary of Philips, however, the device is being marketed under the Philips brand name. As healthcare professionals seek evidence-based and cutting-edge diagnostic solutions for venous diseases, the introduction of such devices is setting standards for minimally invasive solutions that aid them in improving treatment outcomes.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of the U.S. Tariffs

4. Executive Summary

5. Global Peripheral Vascular Devices Market Outlook, 2018-2032F

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product Type
      • 5.2.1.1. Peripheral Vascular Stents
        • 5.2.1.1.1. Balloon-expandable Stents
        • 5.2.1.1.2. Self-expanding Stents
        • 5.2.1.1.3. Drug-eluting Stents
        • 5.2.1.1.4. Bare-metal Stents
        • 5.2.1.1.5. Others
      • 5.2.1.2. Angioplasty Balloons
        • 5.2.1.2.1. Plain Old Balloon Angioplasty (POBA)
        • 5.2.1.2.2. Drug-coated Balloons (DCB)
        • 5.2.1.2.3. Scoring and Cutting Balloons
      • 5.2.1.3. Plaque Modification Devices
        • 5.2.1.3.1. Atherectomy Devices
        • 5.2.1.3.2. Thrombectomy Devices
      • 5.2.1.4. Inferior Vena Cava (IVC) Filters
        • 5.2.1.4.1. Permanent Filters
        • 5.2.1.4.2. Retrievable Filters
      • 5.2.1.5. Hemodynamic Flow Alteration Devices
        • 5.2.1.5.1. Chronic Total Occlusion Devices
        • 5.2.1.5.2. Embolic Protection Devices
      • 5.2.1.6. Catheters
        • 5.2.1.6.1. Angiography Catheters
        • 5.2.1.6.2. Guiding Catheters
        • 5.2.1.6.3. OCT Catheters
      • 5.2.1.7. Others
        • 5.2.1.7.1. Guidewires
        • 5.2.1.7.2. Vascular Closure Devices
        • 5.2.1.7.3. Introducer Sheaths
        • 5.2.1.7.4. Others
    • 5.2.2. By Application
      • 5.2.2.1. Peripheral Arterial Disease (PAD)
      • 5.2.2.2. Aneurysms
      • 5.2.2.3. Venous Thromboembolism
      • 5.2.2.4. Others
    • 5.2.3. By End-user
      • 5.2.3.1. Hospitals and Surgical Centers
      • 5.2.3.2. Ambulatory Surgical Centers (ASCs)
      • 5.2.3.3. Academic and Research Institutes
      • 5.2.3.4. Others
    • 5.2.4. By Region
      • 5.2.4.1. North America
      • 5.2.4.2. Europe
      • 5.2.4.3. Asia-Pacific
      • 5.2.4.4. South America
      • 5.2.4.5. Middle East and Africa
    • 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 5.3. Market Map Analysis, 2024
    • 5.3.1. By Product Type
    • 5.3.2. By Application
    • 5.3.3. By End-user
    • 5.3.4. By Region

6. North America Peripheral Vascular Devices Market Outlook, 2018-2032F

  • 6.1. Market Size Analysis & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share Analysis & Forecast
    • 6.2.1. By Product Type
      • 6.2.1.1. Peripheral Vascular Stents
        • 6.2.1.1.1. Balloon-expandable Stents
        • 6.2.1.1.2. Self-expanding Stents
        • 6.2.1.1.3. Drug-eluting Stents
        • 6.2.1.1.4. Bare-metal Stents
        • 6.2.1.1.5. Others
      • 6.2.1.2. Angioplasty Balloons
        • 6.2.1.2.1. Plain Old Balloon Angioplasty (POBA)
        • 6.2.1.2.2. Drug-coated Balloons (DCB)
        • 6.2.1.2.3. Scoring and Cutting Balloons
      • 6.2.1.3. Plaque Modification Devices
        • 6.2.1.3.1. Atherectomy Devices
        • 6.2.1.3.2. Thrombectomy Devices
      • 6.2.1.4. Inferior Vena Cava (IVC) Filters
        • 6.2.1.4.1. Permanent Filters
        • 6.2.1.4.2. Retrievable Filters
      • 6.2.1.5. Hemodynamic Flow Alteration Devices
        • 6.2.1.5.1. Chronic Total Occlusion Devices
        • 6.2.1.5.2. Embolic Protection Devices
      • 6.2.1.6. Catheters
        • 6.2.1.6.1. Angiography Catheters
        • 6.2.1.6.2. Guiding Catheters
        • 6.2.1.6.3. OCT Catheters
      • 6.2.1.7. Others
        • 6.2.1.7.1. Guidewires
        • 6.2.1.7.2. Vascular Closure Devices
        • 6.2.1.7.3. Introducer Sheaths
        • 6.2.1.7.4. Others
    • 6.2.2. By Application
      • 6.2.2.1. Peripheral Arterial Disease (PAD)
      • 6.2.2.2. Aneurysms
      • 6.2.2.3. Venous Thromboembolism
      • 6.2.2.4. Others
    • 6.2.3. By End-user
      • 6.2.3.1. Hospitals and Surgical Centers
      • 6.2.3.2. Ambulatory Surgical Centers (ASCs)
      • 6.2.3.3. Academic and Research Institutes
      • 6.2.3.4. Others
    • 6.2.4. By Country Share
      • 6.2.4.1. United States
      • 6.2.4.2. Canada
      • 6.2.4.3. Mexico
  • 6.3. Country Market Assessment
    • 6.3.1. United States Peripheral Vascular Devices Market Outlook, 2018-2032F*
      • 6.3.1.1. Market Size Analysis & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share Analysis & Forecast
        • 6.3.1.2.1. By Product Type
          • 6.3.1.2.1.1. Peripheral Vascular Stents
          • 6.3.1.2.1.1.1. Balloon-expandable Stents
          • 6.3.1.2.1.1.2. Self-expanding Stents
          • 6.3.1.2.1.1.3. Drug-eluting Stents
          • 6.3.1.2.1.1.4. Bare-metal Stents
          • 6.3.1.2.1.1.5. Others
          • 6.3.1.2.1.2. Angioplasty Balloons
          • 6.3.1.2.1.2.1. Plain Old Balloon Angioplasty (POBA)
          • 6.3.1.2.1.2.2. Drug-coated Balloons (DCB)
          • 6.3.1.2.1.2.3. Scoring and Cutting Balloons
          • 6.3.1.2.1.3. Plaque Modification Devices
          • 6.3.1.2.1.3.1. Atherectomy Devices
          • 6.3.1.2.1.3.2. Thrombectomy Devices
          • 6.3.1.2.1.4. Inferior Vena Cava (IVC) Filters
          • 6.3.1.2.1.4.1. Permanent Filters
          • 6.3.1.2.1.4.2. Retrievable Filters
          • 6.3.1.2.1.5. Hemodynamic Flow Alteration Devices
          • 6.3.1.2.1.5.1. Chronic Total Occlusion Devices
          • 6.3.1.2.1.5.2. Embolic Protection Devices
          • 6.3.1.2.1.6. Catheters
          • 6.3.1.2.1.6.1. Angiography Catheters
          • 6.3.1.2.1.6.2. Guiding Catheters
          • 6.3.1.2.1.6.3. OCT Catheters
          • 6.3.1.2.1.7. Others
          • 6.3.1.2.1.7.1. Guidewires
          • 6.3.1.2.1.7.2. Vascular Closure Devices
          • 6.3.1.2.1.7.3. Introducer Sheaths
          • 6.3.1.2.1.7.4. Others
        • 6.3.1.2.2. By Application
          • 6.3.1.2.2.1. Peripheral Arterial Disease (PAD)
          • 6.3.1.2.2.2. Aneurysms
          • 6.3.1.2.2.3. Venous Thromboembolism
          • 6.3.1.2.2.4. Others
        • 6.3.1.2.3. By End-user
          • 6.3.1.2.3.1. Hospitals and Surgical Centers
          • 6.3.1.2.3.2. Ambulatory Surgical Centers (ASCs)
          • 6.3.1.2.3.3. Academic and Research Institutes
          • 6.3.1.2.3.4. Others
    • 6.3.2. Canada
    • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Peripheral Vascular Devices Market Outlook, 2018-2032F

  • 7.1. Germany
  • 7.2. France
  • 7.3. Italy
  • 7.4. United Kingdom
  • 7.5. Russia
  • 7.6. Netherlands
  • 7.7. Spain
  • 7.8. Turkey
  • 7.9. Poland

8. Asia-Pacific Peripheral Vascular Devices Market Outlook, 2018-2032F

  • 8.1. India
  • 8.2. China
  • 8.3. Japan
  • 8.4. Australia
  • 8.5. Vietnam
  • 8.6. South Korea
  • 8.7. Indonesia
  • 8.8. Philippines

9. South America Peripheral Vascular Devices Market Outlook, 2018-2032F

  • 9.1. Brazil
  • 9.2. Argentina

10. Middle East and Africa Peripheral Vascular Devices Market Outlook, 2018-2032F

  • 10.1. Saudi Arabia
  • 10.2. UAE
  • 10.3. South Africa

11. Demand Supply Analysis

12. Import and Export Analysis

13. Value Chain Analysis

14. Porter's Five Forces Analysis

15. PESTLE Analysis

16. Pricing Analysis

17. Market Dynamics

  • 17.1. Market Drivers
  • 17.2. Market Challenges

18. Market Trends and Developments

19. Regulatory Landscape

20. Product Launches and Innovations

21. Case Studies

22. Competitive Landscape

  • 22.1. Competition Matrix of Top 5 Market Leaders
  • 22.2. SWOT Analysis for Top 5 Players
  • 22.3. Key Players Landscape for Top 10 Market Players
    • 22.3.1. Boston Scientific Corporation
      • 22.3.1.1. Company Details
      • 22.3.1.2. Key Management Personnel
      • 22.3.1.3. Products and Services
      • 22.3.1.4. Financials (As Reported)
      • 22.3.1.5. Key Market Focus and Geographical Presence
      • 22.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 22.3.2. Koninklijke Philips N.V
    • 22.3.3. Abbott Laboratories
    • 22.3.4. Edward Lifesciences Corporation
    • 22.3.5. Medtronic Inc.
    • 22.3.6. Teleflex Incorporated
    • 22.3.7. Becton, Dickinson, and Company
    • 22.3.8. Edward Lifesciences Corporation
    • 22.3.9. Terumo Corporation
    • 22.3.10. Stryker Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

23. Strategic Recommendations

24. About Us and Disclaimer

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 3. Global Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 4. Global Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 5. Global Peripheral Vascular Devices Market Share (%), By Region, 2018-2032F
  • Figure 6. North America Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 7. North America Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 8. North America Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 9. North America Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 10. North America Peripheral Vascular Devices Market Share (%), By Country, 2018-2032F
  • Figure 11. United States Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 12. United States Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 13. United States Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 14. United States Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 15. Canada Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 16. Canada Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 17. Canada Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 18. Canada Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 19. Mexico Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 20. Mexico Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 21. Mexico Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 22. Mexico Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 23. Europe Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Europe Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 25. Europe Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 26. Europe Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 27. Europe Peripheral Vascular Devices Market Share (%), By Country, 2018-2032F
  • Figure 28. Germany Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Germany Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 30. Germany Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 31. Germany Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 32. France Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 33. France Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 34. France Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 35. France Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 36. Italy Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 37. Italy Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 38. Italy Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 39. Italy Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 40. United Kingdom Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 41. United Kingdom Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 42. United Kingdom Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 43. United Kingdom Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 44. Russia Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Russia Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 46. Russia Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 47. Russia Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 48. Netherlands Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 49. Netherlands Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 50. Netherlands Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 51. Netherlands Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 52. Spain Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 53. Spain Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 54. Spain Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 55. Spain Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 56. Turkey Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 57. Turkey Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 58. Turkey Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 59. Turkey Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 60. Poland Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 61. Poland Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 62. Poland Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 63. Poland Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 64. South America Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. South America Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 66. South America Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 67. South America Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 68. South America Peripheral Vascular Devices Market Share (%), By Country, 2018-2032F
  • Figure 69. Brazil Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Brazil Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 71. Brazil Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 72. Brazil Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 73. Argentina Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 74. Argentina Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 75. Argentina Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 76. Argentina Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 77. Asia-Pacific Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 78. Asia-Pacific Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 79. Asia-Pacific Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 80. Asia-Pacific Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 81. Asia-Pacific Peripheral Vascular Devices Market Share (%), By Country, 2018-2032F
  • Figure 82. India Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 83. India Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 84. India Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 85. India Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 86. China Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 87. China Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 88. China Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 89. China Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 90. Japan Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Japan Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 92. Japan Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 93. Japan Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 94. Australia Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 95. Australia Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 96. Australia Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 97. Australia Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 98. Vietnam Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 99. Vietnam Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 100. Vietnam Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 101. Vietnam Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 102. South Korea Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 103. South Korea Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 104. South Korea Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 105. South Korea Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 106. Indonesia Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. Indonesia Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 108. Indonesia Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 109. Indonesia Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 110. Philippines Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 111. Philippines Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 112. Philippines Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 113. Philippines Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 114. Middle East & Africa Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 115. Middle East & Africa Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 116. Middle East & Africa Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 117. Middle East & Africa Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 118. Middle East & Africa Peripheral Vascular Devices Market Share (%), By Country, 2018-2032F
  • Figure 119. Saudi Arabia Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 120. Saudi Arabia Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 121. Saudi Arabia Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 122. Saudi Arabia Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 123. UAE Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 124. UAE Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 125. UAE Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 126. UAE Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 127. South Africa Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 128. South Africa Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 129. South Africa Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 130. South Africa Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 131. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 132. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 133. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024